BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 25588079)

  • 1. Timing of subsequent new tumors in patients who present with basal cell carcinoma or cutaneous squamous cell carcinoma.
    Wehner MR; Linos E; Parvataneni R; Stuart SE; Boscardin WJ; Chren MM
    JAMA Dermatol; 2015 Apr; 151(4):382-8. PubMed ID: 25588079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Topical Calcineurin Inhibitor Use and Keratinocyte Carcinoma Risk Among Adults With Atopic Dermatitis.
    Asgari MM; Tsai AL; Avalos L; Sokil M; Quesenberry CP
    JAMA Dermatol; 2020 Oct; 156(10):1066-1073. PubMed ID: 32785626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin Cancer Risk in Hematopoietic Stem-Cell Transplant Recipients Compared With Background Population and Renal Transplant Recipients: A Population-Based Cohort Study.
    Omland SH; Gniadecki R; Hædersdal M; Helweg-Larsen J; Omland LH
    JAMA Dermatol; 2016 Feb; 152(2):177-83. PubMed ID: 26454261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012.
    Rogers HW; Weinstock MA; Feldman SR; Coldiron BM
    JAMA Dermatol; 2015 Oct; 151(10):1081-6. PubMed ID: 25928283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of subsequent cutaneous malignancy in patients with prior keratinocyte carcinoma: a systematic review and meta-analysis.
    Flohil SC; van der Leest RJ; Arends LR; de Vries E; Nijsten T
    Eur J Cancer; 2013 Jul; 49(10):2365-75. PubMed ID: 23608733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tretinoin and the prevention of keratinocyte carcinoma (Basal and squamous cell carcinoma of the skin): a veterans affairs randomized chemoprevention trial.
    Weinstock MA; Bingham SF; Digiovanna JJ; Rizzo AE; Marcolivio K; Hall R; Eilers D; Naylor M; Kirsner R; Kalivas J; Cole G; Vertrees JE;
    J Invest Dermatol; 2012 Jun; 132(6):1583-90. PubMed ID: 22318383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. History of Keratinocyte Carcinoma and Risk of Melanoma: A Prospective Cohort Study.
    Wu S; Cho E; Li WQ; Qureshi AA
    J Natl Cancer Inst; 2017 Apr; 109(4):. PubMed ID: 28376160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients with both basal and squamous cell carcinomas are at a lower risk of further basal cell carcinomas than patients with only a basal cell carcinoma.
    Ramachandran S; Rajaratnam R; Smith AG; Lear JT; Strange RC
    J Am Acad Dermatol; 2009 Aug; 61(2):247-51. PubMed ID: 19481292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of subsequent keratinocyte carcinomas after a first diagnosis in Tasmania, Australia.
    Ragaini BS; Blizzard L; Venn A
    Australas J Dermatol; 2023 Feb; 64(1):108-117. PubMed ID: 36269635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risks of different skin tumour combinations after a first melanoma, squamous cell carcinoma and basal cell carcinoma in Dutch population-based cohorts: 1989-2009.
    van der Leest RJT; Hollestein LM; Liu L; Nijsten T; de Vries E
    J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):382-389. PubMed ID: 28898461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial.
    Christian JB; Lapane KL; Hume AL; Eaton CB; Weinstock MA;
    J Natl Cancer Inst; 2008 Sep; 100(17):1223-32. PubMed ID: 18728281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The presence of betapapillomavirus antibodies around transplantation predicts the development of keratinocyte carcinoma in organ transplant recipients: a cohort study.
    Genders RE; Mazlom H; Michel A; Plasmeijer EI; Quint KD; Pawlita M; van der Meijden E; Waterboer T; de Fijter H; Claas FH; Wolterbeek R; Feltkamp MCW; Bouwes Bavinck JN
    J Invest Dermatol; 2015 May; 135(5):1275-1282. PubMed ID: 25347116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients.
    Fortina AB; Piaserico S; Caforio AL; Abeni D; Alaibac M; Angelini A; Iliceto S; Peserico A
    Arch Dermatol; 2004 Sep; 140(9):1079-85. PubMed ID: 15381547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occurrence of other cancers among patients with prior basal cell and squamous cell skin cancer.
    Karagas MR; Greenberg ER; Mott LA; Baron JA; Ernster VL
    Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):157-61. PubMed ID: 9488591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of basal and cutaneous squamous cell carcinoma in the U.K. 2013-15: a cohort study.
    Venables ZC; Nijsten T; Wong KF; Autier P; Broggio J; Deas A; Harwood CA; Hollestein LM; Langan SM; Morgan E; Proby CM; Rashbass J; Leigh IM
    Br J Dermatol; 2019 Sep; 181(3):474-482. PubMed ID: 30864158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Between Health Maintenance Practices and Skin Cancer Risk as a Possible Source of Detection Bias.
    Drucker AM; Li WQ; Savitz DA; Weinstock MA; Han J; Li T; Qureshi AA; Cho E
    JAMA Dermatol; 2019 Mar; 155(3):353-357. PubMed ID: 30586131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival of patients with basal cell carcinoma, squamous cell carcinoma, and squamous cell carcinoma in situ: A whole population study.
    Sharp K; Olafsdottir EJ; Sahni DR; Madsen S; Grant-Kels JM; Kristjansson A; Hoyt DW; Ungar JP; Frigerio A; Jonasson JG; Adalsteinsson JA
    J Am Acad Dermatol; 2024 Jan; 90(1):91-97. PubMed ID: 37758026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occupation and keratinocyte cancer risk: a population-based case-control study.
    Marehbian J; Colt JS; Baris D; Stewart P; Stukel TA; Spencer SK; Karagas MR
    Cancer Causes Control; 2007 Oct; 18(8):895-908. PubMed ID: 17638107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Forearm hair density and risk of keratinocyte cancers in Australian adults.
    von Schuckmann LA; Hughes MC; Green AC; van der Pols JC
    Arch Dermatol Res; 2016 Nov; 308(9):617-624. PubMed ID: 27590883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of State and Federal Malpractice Litigation of Medical Liability Claims for Keratinocyte Carcinoma, 1968 to 2018.
    Tripathi R; Ezaldein HH; Rajkumar K; Bordeaux JS; Scott JF
    JAMA Dermatol; 2019 Jul; 155(7):812-818. PubMed ID: 31090874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.